Shalby Ltd's Q4FY25 Quarter Results
- 30 May 2025
Result Summary
- Shalby Ltd reported a 11.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 19.7%.
- Its expenses for the quarter were down by 15.4% QoQ and up 20.4% YoY.
- The net profit decreased 636.5% QoQ and increased 15.4% YoY.
- The earnings per share (EPS) of Shalby Ltd stood at 1.5 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 249.22 | 281.05 | 208.16 | -11.3% | 19.7% |
Total Expenses | 227.44 | 268.71 | 188.97 | -15.4% | 20.4% |
Profit Before Tax | 21.78 | 12.35 | 19.19 | 76.4% | 13.5% |
Tax | 5.74 | 15.34 | 5.29 | -62.6% | 8.5% |
Profit After Tax | 16.04 | -2.99 | 13.90 | -636.5% | 15.4% |
Earnings Per Share | 1.50 | -0.30 | 1.30 | -600.0% | 15.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Shalby Ltd is a company that is primarily known for its operations in the healthcare sector. It is well-regarded for providing a wide range of healthcare services, including specialty treatments and surgeries. The company is recognized for its network of multi-specialty hospitals across various regions and is committed to delivering high-quality medical care. As of the latest update, there haven't been any major publicized developments, mergers, or acquisitions by Shalby Ltd. The company's consistent focus on expanding its healthcare services and improving patient care remains a significant aspect of its business strategy. However, specific details about recent developments are not available in the provided data.
Revenue
In the fourth quarter of the fiscal year 2025, Shalby Ltd reported a total income of ₹249.22 crores. This represents a decrease of 11.3% from the preceding quarter (Q3FY25), where the total income was ₹281.05 crores. Comparing year-over-year (YoY), the total income increased by 19.7% from ₹208.16 crores in the fourth quarter of the fiscal year 2024. This YoY growth illustrates a positive trend in the company's revenue generation over the year, despite the QoQ decline observed in the latest quarter. The total income serves as a critical indicator of the company’s ability to generate revenue from its core operations in the healthcare sector.
Profitability
Shalby Ltd's profitability metrics for Q4FY25 show a profit before tax of ₹21.78 crores, which is a substantial increase of 76.4% compared to the previous quarter's (Q3FY25) profit before tax of ₹12.35 crores. On a YoY basis, this figure reflects a 13.5% increase from ₹19.19 crores reported in Q4FY24, indicating improved profitability over the year. The tax expense for the quarter was ₹5.74 crores, showing a significant decrease of 62.6% QoQ from ₹15.34 crores in Q3FY25. Correspondingly, the profit after tax surged to ₹16.04 crores in Q4FY25, a marked improvement compared to a loss of ₹2.99 crores in Q3FY25. Year-over-year, the profit after tax increased by 15.4% from ₹13.90 crores in Q4FY24. The earnings per share for Q4FY25 stood at ₹1.50, up from a loss of ₹0.30 per share in Q3FY25, and up 15.4% YoY from ₹1.30 in Q4FY24.
Operating Metrics
The total expenses for Shalby Ltd in Q4FY25 amounted to ₹227.44 crores, which reflects a significant reduction of 15.4% compared to the previous quarter (Q3FY25), where expenses were ₹268.71 crores. When compared year-over-year, total expenses increased by 20.4% from the same quarter in the previous year (Q4FY24), where expenses were ₹188.97 crores. This suggests varying dynamics in the company's cost structure over the quarters. Additionally, the performance metrics for profitability, such as profit before tax and profit after tax, show substantial improvements both QoQ and YoY, which can be attributed to effective cost management and possibly other operational efficiencies. The financial data indicates that Shalby Ltd has experienced notable fluctuations in its operating expenses and profitability metrics over the specified periods.